SCHEMBL30296174

SCHEMBL30296174

Nc1ncc(Cl)nc1-c1cccc(Cl)c1Cl

nearest known ligand 0.55

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
MAPK1 P28482 2/20 0.55
CYP2D6 P10635 1/20 0.55
MAOA P21397 1/20 0.55
ADRA1A P35348 1/20 0.55
SCN4A P35499 1/20 0.55
BLM P54132 1/20 0.55
PMP22 Q01453 1/20 0.55
PDE3A Q14432 1/20 0.55
SCN5A Q14524 1/20 0.55
SCN9A Q15858 1/20 0.55
SCN2A Q99250 1/20 0.55
SCN3A Q9NY46 1/20 0.55
SCN10A Q9Y5Y9 1/20 0.55
PTPN11 Q06124 18/20 0.51
MAPK3 P27361 1/20 0.45
KCNH2 Q12809 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29041371 1.00 MAPK1 (0.55) MAPK1CYP2D6MAOAADRA1ASCN4A
SCHEMBL7059600 0.87 MAPK1 (0.59) MAPK1CYP2D6MAOAADRA1ASCN4A
SCHEMBL29542922 0.87 MAPK1 (0.59) MAPK1CYP2D6MAOAADRA1ASCN4A
SCHEMBL30502499 0.77 MAPK1 (0.56) MAPK1CYP2D6MAOAADRA1ASCN4A
SCHEMBL30295969 0.77 MAPK1 (0.44) MAPK1CYP2D6MAOAADRA1ASCN4A
SCHEMBL30295800 0.77 PTPN11 (0.45) MAPK1CYP2D6MAOAADRA1ASCN4A
SCHEMBL19785050 0.77 MAPK1 (0.44) MAPK1CYP2D6MAOAADRA1ASCN4A
SCHEMBL976695 0.77 SCN2A (0.62) MAPK1CYP2D6MAOAADRA1ASCN4A
SCHEMBL19785030 0.77 PTPN11 (0.45) MAPK1CYP2D6MAOAADRA1ASCN4A
SCHEMBL30296035 0.76 ALOX15 (0.46) MAPK1CYP2D6MAOAADRA1ASCN4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116478131-A 2, 5-disubstituted and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-07-25 CN disclosed
CN-116478132-A 2, 5-disubstituted and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-07-25 CN disclosed
CN-109983001-B 2, 5-disubstituted 3-methylpyrazines and 2,5, 6-trisubstituted 3-methylpyrazines as allosteric SHP2 inhibitors 锐新医药公司 2023-04-04 CN disclosed